UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study

Canadian respiratory journal, 2018-01, Vol.2018, p.9836820-5

2018

Volltextzugriff (PDF)

MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways

Experimental & molecular medicine, 2018-04, Vol.50 (4), p.1-11

2018

Volltextzugriff (PDF)

Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in China

Chinese medical journal, 2022-08, Vol.135 (15), p.1837-1845

2022

Volltextzugriff (PDF)

Integrative analysis reveals key mRNA and long non-coding RNA interaction in idiopathic pulmonary arterial hypertension

Archives of medical science, 2023-01, Vol.19 (6), p.1879-1888

2023

Volltextzugriff (PDF)

Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors

PloS one, 2014-05, Vol.9 (5), p.e97009-e97009

2014

Volltextzugriff (PDF)

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients

Canadian respiratory journal, 2018-01, Vol.2018, p.9629570-6

2018

Volltextzugriff (PDF)

Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study

Canadian respiratory journal, 2018-01, Vol.2018, p.3148259-7

2018

Volltextzugriff (PDF)

Apply pressure-strain loop to quantify myocardial work in pulmonary hypertension: A prospective cohort study

Frontiers in cardiovascular medicine, 2022-12, Vol.9, p.1022987-1022987

2022

Volltextzugriff (PDF)

Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics

BMC cardiovascular disorders, 2022-02, Vol.22 (1), p.56-56, Article 56

2022

Volltextzugriff (PDF)

The Balance between the Left and Right Ventricular Deformation Evaluated by Speckle Tracking Echocardiography Is a Great Predictor of the Major Adverse Cardiac Event in Patients with Pulmonary Hypertension

Diagnostics (Basel), 2022-09, Vol.12 (9), p.2266

2022

Volltextzugriff (PDF)

Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

Frontiers in cardiovascular medicine, 2024-02, Vol.11, p.1371699-1371699

2024

Volltextzugriff (PDF)

Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

Frontiers in cardiovascular medicine, 2023-06, Vol.10, p.1142721-1142721

2023

Volltextzugriff (PDF)

Risk prediction in medically treated chronic thromboembolic pulmonary hypertension

BMC pulmonary medicine, 2021-04, Vol.21 (1), p.128-128, Article 128

2021

Volltextzugriff (PDF)

The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort study

Frontiers in cardiovascular medicine, 2022-08, Vol.9, p.908215-908215

2022

Volltextzugriff (PDF)

Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysis

Frontiers in cardiovascular medicine, 2022-08, Vol.9, p.983803-983803

2022

Volltextzugriff (PDF)

Ten year risk assessment of ischemic cardiovascular disease and intervention analysis among middle-aged residents with moderate risk and above in a Shanghai-based community

Family medicine and community health, 2017-05, Vol.5 (1), p.92-100

2017

Volltextzugriff (PDF)

Gender differences in epicardial and tissue-level reperfusion in patients undergoing primary angioplasty for acute myocardial infarction

Atherosclerosis, 2011-03, Vol.215 (1), p.203-208

2011

Volltextzugriff (PDF)

Effects of Lipo-Prostaglandin E1 on Pulmonary Hemodynamics and Clinical Outcomes in Patients With Pulmonary Arterial Hypertension

Chest, 2005-08, Vol.128 (2), p.714-719

2005

Volltextzugriff (PDF)

GW25-e1574 Two/three-dimensional echocardiography in the assessment of long-term prognosis in patients with pulmonary arterial hypertension

Journal of the American College of Cardiology, 2014-10, Vol.64 (16), p.C224-C225

2014

Volltextzugriff (PDF)

Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies: A prospective cohort study from China

International journal of cardiology, 2021-03, Vol.326, p.178-183

2021

Volltextzugriff (PDF)

Comparison of epicardial and myocardial perfusions after primary coronary angioplasty for ST-elevation myocardial infarction in patients under and over 75 years of age

Aging clinical and experimental research, 2010-08, Vol.22 (4), p.295-302

2010

Volltextzugriff (PDF)

10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry

Rheumatology (Oxford, England), 2023-11, Vol.62 (11), p.3555-3564

2023

Volltextzugriff (PDF)

Effect of off‐label targeted drugs on long‐term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry

Respirology (Carlton, Vic.), 2024-07, Vol.29 (7), p.614-623

2024

Volltextzugriff (PDF)

A Nomogram for Predicting 3-Year Mortality in Patients with Pulmonary Hypertension due to Left Heart Failure: A Retrospective Analysis of a Prospective Registry Study

Cardiology, 2023-06, Vol.148 (2), p.161-172

2023

Volltextzugriff (PDF)

Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry

Respirology (Carlton, Vic.), 2022-07, Vol.27 (7), p.517-528

2022

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study

MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways

Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in China

Integrative analysis reveals key mRNA and long non-coding RNA interaction in idiopathic pulmonary arterial hypertension

Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients

Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study

Apply pressure-strain loop to quantify myocardial work in pulmonary hypertension: A prospective cohort study

Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics

The Balance between the Left and Right Ventricular Deformation Evaluated by Speckle Tracking Echocardiography Is a Great Predictor of the Major Adverse Cardiac Event in Patients with Pulmonary Hypertension

Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

Risk prediction in medically treated chronic thromboembolic pulmonary hypertension

The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort study

Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysis

Ten year risk assessment of ischemic cardiovascular disease and intervention analysis among middle-aged residents with moderate risk and above in a Shanghai-based community

Gender differences in epicardial and tissue-level reperfusion in patients undergoing primary angioplasty for acute myocardial infarction

Effects of Lipo-Prostaglandin E1 on Pulmonary Hemodynamics and Clinical Outcomes in Patients With Pulmonary Arterial Hypertension

GW25-e1574 Two/three-dimensional echocardiography in the assessment of long-term prognosis in patients with pulmonary arterial hypertension

Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies: A prospective cohort study from China

Comparison of epicardial and myocardial perfusions after primary coronary angioplasty for ST-elevation myocardial infarction in patients under and over 75 years of age

10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry

Effect of off‐label targeted drugs on long‐term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry

A Nomogram for Predicting 3-Year Mortality in Patients with Pulmonary Hypertension due to Left Heart Failure: A Retrospective Analysis of a Prospective Registry Study

Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry

Suchergebnisse filtern